Calorie restriction protects against acute systemic LPS-induced inflammation

被引:2
作者
da Silva, Vanessa-Fernanda [1 ]
Gayger-Dias, Vitor [1 ]
da Silva, Rafaela Sampaio [1 ]
Sobottka, Thomas Michel [1 ]
Cigerce, Anderson [1 ]
Lissner, Lilian Juliana [1 ,2 ]
Wartchow, Krista Mineia [3 ]
Rodrigues, Leticia [1 ]
Zanotto, Caroline [4 ]
Froes, Fernanda Carolina Telles da Silva [1 ]
Seady, Marina [1 ]
Quincozes-Santos, Andre [1 ]
Goncalves, Carlos-Alberto [1 ,5 ]
机构
[1] Univ Fed Rio Grande do Sul UFRGS, Grad Program Biochem, Inst Ciencias Bas Saude ICBS, Porto Alegre, Brazil
[2] Univ Roma La Sapienza, Dipartimento Fisiol & Farmacol Vittorio Erspamer, Rome, Italy
[3] Weill Cornell Med, Brain Hlth Imaging Inst, Dept Radiol, New York, NY USA
[4] Grp Hosp Conceicao, Biochem Lab, Porto Alegre, Brazil
[5] Programa Posgrad Bioquim, Ramiro Barcelos 2600, BR-90035003 Porto Alegre, RS, Brazil
关键词
Astrocyte; caloric restriction; inflammation; GFAP; Hippocampus; LPS; microglia; neuroprotection; LIPOPOLYSACCHARIDE; HIPPOCAMPUS; GLUTATHIONE; ACTIVATION; DISEASE; CORTEX; AGE;
D O I
10.1080/1028415X.2024.2316448
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Caloric restriction (CR) has been proposed as a nutritional strategy to combat chronic diseases, including neurodegenerative diseases, as well as to delay aging. However, despite the benefits of CR, questions remain about its underlying mechanisms and cellular and molecular targets.Objective: As inflammatory processes are the basis or accompany chronic diseases and aging, we investigated the protective role of CR in the event of an acute inflammatory stimulus.Methods: Peripheral inflammatory and metabolic parameters were evaluated in Wistar rats following CR and/or acute lipopolysaccharide (LPS) administration, as well as glial changes (microglia and astrocytes), in two regions of the brain (hippocampus and hypothalamus) involved in the inflammatory response. We used a protocol of 30% CR, for 4 or 8 weeks. Serum and brain parameters were analyzed by biochemical or immunological assays.Results: Benefits of CR were observed during the inflammatory challenge, where the partial reduction of serum interleukin-6, mediated by CR, attenuated the systemic response. In the central nervous system (CNS), specifically in the hippocampus, CR attenuated the response to the LPS, as evaluated by tumor necrosis factor alpha (TNF alpha) levels. Furthermore, in the hippocampus, CR increased the glutathione (GSH) levels, resulting in a better antioxidant response.Discussion: This study contributes to the understanding of the effects of CR, particularly in the CNS, and expands knowledge about glial cells, emphasizing their importance in neuroprotection strategies.
引用
收藏
页码:1237 / 1249
页数:13
相关论文
共 50 条
  • [21] Salidroside protects against caerulein with the LPS-induced severe acute pancreatitis through suppression of oxidative stress and inflammation in mice
    Chen, Cong-Cong
    Wang, Yi-Hong
    Sun, Rong-Yue
    Lu, Xin-Yu
    Xu, Yu-Peng
    Wang, Yong-qiang
    Li, Jiang-Yuan
    Wang, Hong-Wei
    Chen, Ke-Wei
    JOURNAL OF FUNCTIONAL FOODS, 2022, 96
  • [22] Compound GDC, an Isocoumarin Glycoside, Protects against LPS-Induced Inflammation and Potential Mechanisms In Vitro
    Yuqin Zhang
    Guohong Yan
    Chengtao Sun
    Lihong Nan
    Xiaoying Wang
    Wei Xu
    Kedan Chu
    Inflammation, 2019, 42 : 506 - 515
  • [23] Protopine Protects Mice against LPS-Induced Acute Kidney Injury by Inhibiting Apoptosis and Inflammation via the TLR4 Signaling Pathway
    Zhang, Beibei
    Zeng, Mengnan
    Li, Meng
    Kan, Yuxuan
    Li, Benke
    Xu, Ruiqi
    Wu, Yuanyuan
    Wang, Shengchao
    Zheng, Xiaoke
    Feng, Weisheng
    MOLECULES, 2020, 25 (01):
  • [24] Liquiritin, a novel inhibitor of TRPV1 and TRPA1, protects against LPS-induced acute lung injury
    Liu, Zhenhong
    Wang, Pengwen
    Lu, Shanshan
    Guo, Rong
    Gao, Wei
    Tong, Haiying
    Yin, Yin
    Han, Xuezhen
    Liu, Tiantian
    Chen, Xiangyun
    Zhu, Michael X.
    Yang, Zhen
    CELL CALCIUM, 2020, 88
  • [25] Compound GDC, an Isocoumarin Glycoside, Protects against LPS-Induced Inflammation and Potential Mechanisms In Vitro
    Zhang, Yuqin
    Yan, Guohong
    Sun, Chengtao
    Nan, Lihong
    Wang, Xiaoying
    Xu, Wei
    Chu, Kedan
    INFLAMMATION, 2019, 42 (02) : 506 - 515
  • [26] Methoxyeugenol Protects Against Lung Inflammation and Suppresses Neutrophil Extracellular Trap Formation in an LPS-Induced Acute Lung Injury Model
    Antunes, Gessica Luana
    Matzenbacher, Lucas Strassburger
    Costa, Bruna Pasqualotto
    Basso, Bruno de Sousa
    Schneider Levorse, Vitor Giancarlo
    Antunes, Krist Helen
    Munhoz Costa-Ferro, Zaquer Suzana
    de Oliveira, Jarbas Rodrigues
    INFLAMMATION, 2022, 45 (04) : 1534 - 1547
  • [27] Methoxyeugenol Protects Against Lung Inflammation and Suppresses Neutrophil Extracellular Trap Formation in an LPS-Induced Acute Lung Injury Model
    Géssica Luana Antunes
    Lucas Strassburger Matzenbacher
    Bruna Pasqualotto Costa
    Bruno de Sousa Basso
    Vitor Giancarlo Schneider Levorse
    Krist Helen Antunes
    Zaquer Suzana Munhoz Costa-Ferro
    Jarbas Rodrigues de Oliveira
    Inflammation, 2022, 45 : 1534 - 1547
  • [28] Macrolactin A protects against LPS-induced bone loss by regulation of bone remodeling
    Sapkota, Mahesh
    Gao, Ming
    Li, Liang
    Yang, Ming
    Shrestha, Saroj Kumar
    Choi, Hyukjae
    Soh, Yunjo
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 883
  • [29] Glucogallin Attenuates the LPS-Induced Signaling in Macrophages and Protects Mice against Sepsis
    Singh, Rajveer
    Chandel, Shivani
    Ghosh, Arijit
    Matta, Tushar
    Gautam, Anupam
    Bhattacharya, Arka
    Babu, Srivalliputturu Sarath
    Sukla, Soumi
    Nag, Debasish
    Ravichandiran, Velayutham
    Roy, Syamal
    Ghosh, Dipanjan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [30] Resolvin D1 protects mice from LPS-induced acute lung injury
    Wang, Bin
    Gong, Xia
    Wan, Jing-yuan
    Zhang, Li
    Zhang, Zhuo
    Li, Hong-zhong
    Min, Su
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2011, 24 (04) : 434 - 441